Navigation Links
ClinStar, LLC Establishes New Office on the US East Coast
Date:7/19/2011

SAN FRANCISCO, July 19, 2011 /PRNewswire/ -- ClinStar, LLC, an established CRO providing clinical research services in the emerging markets of Russia and Eastern Europe to the pharmaceutical and biotechnology industry, announced today the opening of a new regional office on the East Coast of the United States.

(Photo:  http://photos.prnewswire.com/prnh/20110719/SF36975LOGO)

As a second US location to its headquarters in San Francisco, CA, ClinStar's new office is located at 1000 Park Forty Plaza, Durham, NC. In addition to offering adequate space to centralize ClinStar's regional workforce, the new facility was chosen in large part because of its flexibility to accommodate the company's future growth.

According to President and CEO David Passov, "This is the realization of a major long-term business goal for ClinStar. Our new office further solidifies our commitment to offer our clients the local expertise and knowledge they need to successfully conduct clinical trials in Russia and Eastern Europe while ensuring our business operates in accordance with the proven business and management principles practiced in the West."  

"We are thrilled with the opening of our new office," says Erin King, Executive Director Business Development and Marketing. This move is just one of several important initiatives positioning ClinStar as the leading provider of clinical research services in Russia, Ukraine and parts of Eastern Europe. Our new facility affords not only centralized office space for our employees, but also upscale conference space for hosting meetings with our customers."  

About ClinStar, LLC

ClinStar is one of the most prominent CROs in the emerging markets of Eastern Europe and the Baltics, with more than 10 years of expertise in Phase I-IV clinical studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus with total staff of over 300 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at www.clinstar.com.


'/>"/>
SOURCE ClinStar, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
2. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
3. Pharmaxis Establishes Named Patient Program for Bronchitol
4. First Candidate from Esperances Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept
5. BD Establishes $1.2 Million Fund for Haiti Earthquake Relief Efforts
6. FUJIFILM Establishes Medical Informatics Organization
7. Renhuang Appoints New Director and Establishes Nominating and Compensation Committee
8. Mach 7 Technologies Establishes New Headquarters in Burlington, VT
9. Pfenex Inc. Establishes Reagent Protein Distribution Agreement With Cedarlane Corporation
10. HUYA Biosciences Establishes Strategic Partnership with Sun Yat-sen Universitys School of Pharmaceutical Sciences
11. Varian Medical Systems Establishes Radiotherapy Training Center in Mumbai, India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... PUNE, India , May 3, 2016 /PRNewswire/ ... Market 2016 Research Report provides a basic overview ... manufacturing technology, post which the surgical mesh report ... the market. Complete report on Surgical ... company profiles and 98 tables and figures is ...
(Date:5/2/2016)... NEW YORK , May 2, 2016 Leading Economies ... Growth Ethiopia 10.2 Côte d,Ivoire 8.6 Uzbekistan 8 Ireland 7.8 India 7.3, ... TechSci Research, BRICS nations , which comprises of Brazil ... China and South Africa , registered the fastest ... economic slowdown in China , recession in Brazil ...
(Date:5/2/2016)... N.J. , May 2, 2016  Celsion ... development company, today announced data from the first ... escalating clinical trial (the OVATION Study) combining GEN-1, ... care for the treatment of newly-diagnosed patients with ... followed by interval debulking surgery.  In the first ...
Breaking Medicine Technology:
(Date:5/4/2016)... , ... May 04, 2016 , ... ... certified that their Vasont Universal Integrator (VUI) extension supports the latest release of ... of Adobe FrameMaker 2015 interlace the process of creating, editing and storing XML. ...
(Date:5/3/2016)... ... 2016 , ... An accurate diagnosis is critical to planning ... through expanding activities that embrace training, standards, technology and new methods of making ... , In support of this important work, ASCP is co-sponsoring the inaugural Global ...
(Date:5/3/2016)... ... May 03, 2016 , ... According to an article ... issues related to medical care in the hospital setting, which include excessive wait ... hospital staff. Commenting on this article, the founder of House Call Doctor Los ...
(Date:5/3/2016)... ... ... Desmond-Hellmann, chief executive officer of the Bill & Melinda Gates Foundation, will call on ... address at Georgia State University’s spring commencement on Saturday, May 7 at ... scientist, physician and executive, Desmond-Hellmann leads the Gates Foundation’s efforts to help more children ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... – a web application that helps people assess their risk of developing Alzheimer’s ... app will provide users a “Risk Reduction Score™” that summarizes how their lifestyle ...
Breaking Medicine News(10 mins):